Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to evaluate INCB123667 versus investigator\'s choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1 overexpression.
Epistemonikos ID: 2f2348c802bdccdbb71545ffdd2d6bc1703d90a3
First added on: Oct 10, 2025